Molecular subdivision, including neuroendocrine tumors (NETs) and neuroendocrine carcinomas (NECs), has been established via differential mutations of ATRX/DAXX/MEN1 and TP53/RB1 in the pancreas (13). This evidence concerns the gene RB1 and neuroendocrine carcinoma.